FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

972511000001108: Orciprenaline 20mg tablets 100 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22668701000001111 Orciprenaline 20mg tablets 100 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22668801000001119 Orciprenaline 20mg tablets 100 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Orciprenaline 20mg tablets 100 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Orciprenaline 20mg tablets 100 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Orciprenaline 20mg tablets 100 tablet Has VMP Orciprenaline 20mg tablets true Inferred relationship Existential restriction modifier
Orciprenaline 20mg tablets 100 tablet Has VMP Orciprenaline 20mg tablets false Inferred relationship Existential restriction modifier
Orciprenaline 20mg tablets 100 tablet Is pack of Product containing precisely orciprenaline 20 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Orciprenaline 20mg tablets 100 tablet Has active ingredient Orciprenaline sulfate false Inferred relationship Existential restriction modifier
Orciprenaline 20mg tablets 100 tablet Has active ingredient Orciprenaline false Inferred relationship Existential restriction modifier
Orciprenaline 20mg tablets 100 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Orciprenaline 20mg tablets 100 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Orciprenaline 20mg tablets 100 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Orciprenaline 20mg tablets 100 tablet Has VMP Product containing precisely orciprenaline 20 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Orciprenaline 20mg tablets 100 tablet Has specific active ingredient Orciprenaline sulfate true Inferred relationship Existential restriction modifier
Orciprenaline 20mg tablets 100 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Alupent 20mg tablets (Boehringer Ingelheim Ltd) 100 tablet 10 x 10 tablets Is a True Orciprenaline 20mg tablets 100 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start